Novo Holdings and Lundbeckfonden Portfolio Company IO Biotech Closes Initial Public Offering on the Nasdaq Global Market

/PRNewswire/ — Novo Holdings, a leading international life science investor, and Lundbeckfonden, one of Denmark’s largest commercial foundations funding…